title: Antitumor activities of IL-12 and mechanisms of action.
authors.affiliation: Biologic Therapeutics Program, University of Pittsburgh Cancer Institute, Pa., USA. mshu@med.pitt.edu
authors.forename: M R
authors.initials: MR
authors.lastname: Shurin
authors.forename: C
authors.initials: C
authors.lastname: Esche
authors.forename: J M
authors.initials: JM
authors.lastname: Péron
authors.forename: M T
authors.initials: MT
authors.lastname: Lotze
mesh_terms: D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004195:Disease Models, Animal; D015316:Genetic Therapy; D006801:Humans; D018664:Interleukin-12 / Q000235:genetics / Q000502:physiology* / Q000627:therapeutic use*; D009369:Neoplasms / Q000628:therapy
chemical_list: D000970:Antineoplastic Agents; D018664:Interleukin-12